P Schoenfeld Asset Management LP increased its holdings in shares of Monsanto Company (NYSE:MON) by 34.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 294,111 shares of the basic materials company’s stock after purchasing an additional 74,595 shares during the period. Monsanto makes up 2.2% of P Schoenfeld Asset Management LP’s portfolio, making the stock its 11th biggest position. P Schoenfeld Asset Management LP owned approximately 0.07% of Monsanto worth $35,240,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Pinnacle Financial Partners Inc. bought a new stake in Monsanto in the 2nd quarter valued at approximately $114,000. Bruderman Asset Management LLC bought a new stake in Monsanto in the 2nd quarter valued at approximately $116,000. Tower Research Capital LLC TRC lifted its stake in Monsanto by 230.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after acquiring an additional 750 shares in the last quarter. Armbruster Capital Management Inc. lifted its stake in Monsanto by 12.2% in the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after acquiring an additional 125 shares in the last quarter. Finally, Enterprise Financial Services Corp lifted its stake in Monsanto by 1.2% in the 2nd quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after acquiring an additional 16 shares in the last quarter. Institutional investors and hedge funds own 74.98% of the company’s stock.

In other Monsanto news, EVP Steven Mizell sold 11,526 shares of the stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of the stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the transaction, the vice president now owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock valued at $5,931,934 over the last quarter. Corporate insiders own 0.79% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Monsanto Company (MON) Stake Boosted by P Schoenfeld Asset Management LP” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2017/11/20/monsanto-company-mon-stake-boosted-by-p-schoenfeld-asset-management-lp.html.

A number of brokerages have recently issued reports on MON. Royal Bank Of Canada reiterated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research note on Wednesday, November 15th. Barclays PLC reiterated an “equal weight” rating and set a $124.00 price objective (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. BMO Capital Markets reiterated a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research note on Thursday, October 5th. Piper Jaffray Companies set a $128.00 price objective on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Finally, Vetr lowered Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price on the stock. in a report on Wednesday, August 2nd. Eleven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Monsanto presently has a consensus rating of “Hold” and an average target price of $124.61.

Shares of Monsanto Company (MON) traded down $0.27 during mid-day trading on Monday, hitting $118.33. The company had a trading volume of 1,156,700 shares, compared to its average volume of 1,938,844. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. Monsanto Company has a twelve month low of $100.29 and a twelve month high of $122.79. The company has a market cap of $52,088.87, a P/E ratio of 21.40, a P/E/G ratio of 1.70 and a beta of 1.05.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the prior year, the company earned $0.07 EPS. Monsanto’s revenue for the quarter was up 4.8% on a year-over-year basis. analysts anticipate that Monsanto Company will post 5.74 EPS for the current year.

Monsanto Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.